New strategies in the biological therapy of inflammatory bowel disease based on individual immunophenotypes
- Prosjektnummer
- SFP888-09
- Ansvarlig person
- Jon Florholmen
- Institusjon
- Universitetssykehuset Nord-Norge HF
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Oral and gastrointestinal
- Forskningsaktivitet
- 2. Aetiology
The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease.
Scand J Gastroenterol 2012 Oct;47(10):1200-10. Epub 2012 aug 6
PMID: 22861799 - Inngår i doktorgradsavhandlingen
Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis.
Scand J Gastroenterol 2012 May;47(5):538-47.
PMID: 22486187 - Inngår i doktorgradsavhandlingen
TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
Cytokine 2011 Dec;56(3):633-40. Epub 2011 sep 25
PMID: 21945121 - Inngår i doktorgradsavhandlingen
Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis
Submitted Scand J of Gastr, invited to revise
TH1 and TH2 interactions in untreated inflamed mucosa of IBD, and their potential to mediate the inflammation
innsendt Cytokine 2010
Mucosal TNF-alpha levels in Crohn’s disease treated with adalimumab to an apparently healed mucosa, and the impact on time to re
Inflammatory Bowel Diseases 2011, suppl vol 17, 1, s37 (Abstract Advances in IBD, Miami Florida, Dec 2010)
IL-17 gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative col
Inflammatory Bowel Diseases 2011, suppl vol 17, 1, s16 (Abstract Advances in IBD, Miami Florida Dec 2010)
Normalization of Mucosal TNF-alpha as a criterion when to stop treatment with anti TNF in UC patients? A preliminary report
Abstract ECCO 24-16 febr 2011
Mucosal TNF-alpha level as a criterion for when to discontinue treatment with adalimumab in patients with Crohn’s disease? A pre
Abstract ECCO, Dublin 24-26. febr
TH1 and TH2 interactions in untreated inflamed mucosa of IBD, and their potential to mediate the inflammation
Inflammatory Bowel Diseases 2011, suppl vol 17, 1, s16 (Abstract Advances in IBD, Miami Florida Dec 2010)
Short and long term clinical outcome of infliximab in fulminant ulcerative colitis
Ulcers. 2011: Volume 2011, Article ID 156407, 7 pages. doi:10.1155/2011/156407
Short and long term clinical outcome of infliximab in fulminant ulcerative colitis
Abstract ECCO, Dublin 24-26. febr 2011
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport, Helse Nord